Axis Experts Present, Fall 2024

By Denise Purdie Andrews This Fall, Axis’ expert toxicologists can be found speaking in multiple venues, helping to educate our clients and share expertise with other forensic scientists. The National Association of Medical Examiner (NAME) 2024 Annual Meeting,...

Drug Primer: Designer Benzodiazepines

By Kevin Shanks, D-ABFT-FT What are Designer Benzodiazepines?  Designer benzodiazepines are substances synthesized to mimic the effects of traditional benzodiazepines, which are commonly prescribed for anxiety, insomnia, and other conditions. Unlike their...

Axis Recognizes Postdoctoral Fellows

Axis is pleased to recognize the four Forensic Medicine Fellows that recently completed Axis’  toxicology rotation.  The rotation  is a week-long virtual program where participants reviewed many aspects of a modern forensic toxicology operation, including the...

Change to Third Party Storage Requests

Axis Forensic Toxicology has historically offered a service to store casework for a third party (typically a family member or law office) once our clients authorize a release. This has effectively been a behind-the-scenes service that benefits third parties, but...

Carfentanil Through the Years: A Look at Data From 2016-2024

By Stuart Kurtz, D-ABFT-FT Last month, Axis was represented at the Midwest Association for Toxicology and Therapeutic Drug Monitoring’s annual meeting. Toxicologist Stuart Kurtz gave a presentation on the lab’s detections of carfentanil since Axis started testing for...

Quantitative vs. Qualitative Testing

By Kevin Shanks, M.S., D-ABFT-FT To quantify or not? That is the question. If you regularly read forensic toxicology reports, then you know laboratory tests can be qualitative or quantitative. Qualitative tests only provide a positive/present or negative result. ...